Telaprevir(CAS: 402957-28-2)

Telaprevir is an antiviral medication used primarily in the treatment of chronic hepatitis C. It belongs to a class of drugs known as protease inhibitors and works by blocking the action of the hepatitis C virus (HCV) protease enzyme. Its chemical formula is C19H21N3O3S, and it is a white to off-white crystalline solid with moderate solubility in water and organic solvents. Telaprevir is also known by the trade name Incivek.

Telaprevir is mainly used in combination with other drugs to treat genotype 1 hepatitis C virus infections. It is effective in reducing viral load and is part of a regimen that includes ribavirin and pegylated interferon. Additionally, it has been studied for potential applications in antiviral research and may be used in other therapeutic areas. Telaprevir (CAS: 402957-28-2) is also relevant in pharmaceutical development for similar viral targets.

Telaprevir is generally considered safe when used as directed in medical settings. However, it may cause side effects such as skin rash, fatigue, and gastrointestinal issues. Proper handling and protective measures are necessary during manufacturing and research to minimize exposure. Safety standards for Telaprevir (CAS: 402957-28-2) are established by regulatory agencies to ensure its safe use in both clinical and industrial contexts.

Telaprevir should be stored in a cool, dry, and dark place, away from moisture and direct sunlight. It is typically kept in a sealed container at a temperature below 25°C. Proper storage conditions are essential to maintain its stability and efficacy. For long-term storage, it is recommended to store Telaprevir (CAS: 402957-28-2) in airtight containers to prevent degradation.